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ABSTRACT 
 
 
Sharma, Amit. Ph.D., Biomedical Sciences Program, Wright State University, 2009. 
The in vitro Interactions between Tubulin and HIV-1 Rev require Rev’s Multimerization 
and Arginine Rich Motifs. 
 
 
Rev is a 13 kDa regulatory HIV protein essential for viral replication.  It trans-
activates expression of late viral proteins by multimerizing onto target mRNA and 
promoting their export into the cytoplasm. During attempts to find the solution conditions 
needed to study Rev structure, Watts et al. (2000) discovered that Rev depolymerizes 
microtubules (MTs) in vitro through the formation of ringed tubulin intermediates called 
Rev-tubulin toroids (RTTs). Rev interactions with MTs are specific and are thought to 
mimic the mechanism of Kinesin-13 proteins, themselves potent MT depolymerases that 
regulate the assembly of the mitotic spindle.  If Rev and Kinesin-13 proteins share a 
common mechanism, then Rev mediated MT depolymerization and RTT formation will 
require Rev multimerization and its arginine-rich motif (ARM). 
If Rev multimerization is essential, then multimerization defective mutants should 
not depolymerize MTs and form RTTs.  To test this hypothesis, a combination of 
sedimentation, gel filtration and visual assays were used to compare the activities of wild-
type Rev with the multimerization defective mutant Rev M4 (M4).  Both wild-type Rev 
and M4 are able to bind tubulin heterodimers and form high molecular complexes. 
However, these complexes are not RTTs. M4 also binds GMPCPP-stabilized MTs but 
unlike wild-type Rev, it neither depolymerizes MTs nor forms RTTs. These data show 
that Rev multimerization is important for MT depolymerization although it is unclear 
whether it is involved in targeting Rev to MT ends or provides the force required for 
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depolymerization.  Because M4 promotes MT bundling, this mutation is concluded to 
subtly affect Rev tertiary structure such that the relative orientation of Rev monomers 
within a multimer is altered in a manner that allows MT cross-linking.  
These same assays were also used to test the hypothesis that the ARM is also 
important for Rev-tubulin interactions. In this instance, the activities of wild-type Rev 
were compared to the M6 mutant (M6), a well-characterized substitution-deletion mutant 
in the ARM predicted to perturb binding, depolymerization and RTT formation.  The M6 
mutation affects RTT formation when mixed with tubulin heterodimers, reducing both 
ring size and the amount of complexes that can be sedimented.  In addition, M6 is unable 
to depolymerize GMPCPP-stabilized MTs through an apparent inability to bind MT.  
Results presented here suggest Rev possesses only a single MT binding motif present in 
the ARM. Some residues in this region are critical for binding MT ends where 
depolymerization occurs. These conclusions are also consistent with the hypothesis that 
Rev interacts with MTs by a mechanism shared with Kinesin-13 proteins, themselves 
potent cellular MT depolymerases.  
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INTRODUCTION 
 Human Immunodeficiency Virus-1 (HIV-1) is a causative agent of Acquired 
Immune Deficiency Syndrome or AIDS (Malim and Pollard, 1998; Hope et al., 
2001). Millions of people die of AIDS every year. Although the current therapeutic 
strategy slows the intensity of AIDS infection there is still no known cure for AIDS. 
Consequently, research aimed at understanding the regulation of infection and 
identifying novel HIV targets is important.  Rev is such a target. 
Rev is a 116 amino acid, arginine-rich protein essential for replication of the 
HIV (Pollard and Malim, 1998). It activates late viral gene expression by promoting 
nuclear export of under-spliced viral mRNAs normally retained and degraded in the 
nucleus (Figure 1) (Malim and Cullen, 1989a; Malim et al., 1991).  Rev has an 
arginine-rich motif (ARM, residues 34-62) that recognizes these RNAs by binding to 
a 351-nucleotide, stem loop structure present within an intron called the Rev 
Response Element (RRE) (Figure 2). Mutations in the ARM inhibits expression of 
late viral genes by inhibiting RRE binding as measured by functional assays 
monitoring expression of late viral gene products such as gag and env and assays 
monitoring RRE binding, e.g., gel retardation assays and surface plasmon resonance  
(Malim et al., 1991, Pollard and Malim, 1998; Van Ryk and Venkatesan, 1999). 
Amino acid substitutions and/or deletions of clustered arginine residues in the ARM, 
amino acids 38-39 and 41-44 (e.g., M5 and M6 mutations, respectively), profoundly 
limit Rev binding to RRE (Malim et al., 1989b; Hammerschmidt et al., 1994; Pollard 
and Malim, 1998; Brice et al., 1999) (Table 1). Additional RNA footprinting 
experiments confirm arginines 38, 39, 50, and 66 are important for binding the RRE 
(Jensen et al., 1995).  
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Figure 1: The Biological Function of Rev. A) HIV-1 Rev transcribes into 
completely spliced and RRE containing incompletely spliced transcripts. B) 
Incompletely spliced transcripts are not transported into the cytoplasm and are 
degraded. C) Completely spliced transcripts are transported to the cytoplasm and are 
translated into Rev, Tat and Nef. D) Translated Rev is transported to the nucleus by 
binding Importin β. E, F) Rev binds and multimerizes on to RRE. G) Multimerization 
stimulates Crm-1 binding to Rev’s NES.  This complex is stabilized by Ran-GTP 
binding and enables export of Rev-RRE complexes. RRE containing mRNAs are then 
translated into the structural proteins (Gag, Env, Pol, Vif, Vpr) of the virus.  
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 4 
Figure 2: Domain Structure of Rev. A) The domain structure of Rev showing the 
multimerization motif-1 residing in helix-1, a poly-proline loop, and the ARM and 
multimerization motif-2 (mult.2) present in helix-2. This figure also shows the 
locations of the NES and the M4 and M6 mutations. B) Shows the sequence similarity 
shared between Rev and the motor domain of MCAK. Residues marked in red are 
identical and those marked in blue are conserved substitutions.  
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B.  
 
                                   
  
                                                                               
 
              
        
 
 
Rev M4 
YSNDDL 
23,24,26 
Rev M6 
RRRRDL 
41-44 
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Table 1: Summary of mutants used in this study. The table shows the mutants of 
Rev and their functional properties (Malim and Cullen, 1991). 
 
 
 
Rev Mutant Mutation Multimerization RRE 
Binding 
Rev M4 YSN(23,25,26) 
DDL 
              -           + 
Rev M5 RR(38,39) DL               +           - 
Rev M6 RRRR(41-44) DL               +           - 
Rev M7 SIS(54-56)  I               -          + 
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The RRE consist of a series of intramolecular double stranded RNA stems and single 
stranded loops found only within the 3’ introns of viral RNAs (Daly et al., 1989; 
Malim et al., 1989; Mann et al., 1994; Malim and Pollard, 1998). Rev binds one such 
stem-loop structure called SLIIB with ≈1 nM affinity (Daly et al., 1989; Malim et al., 
1989; Mann et al., 1994; Malim and Pollard, 1998). Specifically, it binds the stem of 
SLIIB that forms a distorted helix due to non-Watson-Crick purine-purine base 
pairing (G47-A73 and G4-G71) (Bartel et al., 1991; Malim and Polard, 1998). Initial 
binding of a Rev monomer is mediated by nonspecific electrostatic interactions 
between arginine residues of the ARM and negatively charged phosphate backbone of 
RRE as determined by gel retardation and NMR (Daly et al., 1993; Battiste et al., 
1996; Belasco et al., 1996; Van Ryk and Venkatesan, 1999).  
Rev binding is insufficient to stimulate export of RRE-containing transcripts; 
however, binding the SLIIB site stimulates partially cooperative binding of four 
additional Rev monomers (Malim et al., 1989; Daly et al., 1993; Battiste et al., 1996; 
Belasco et al., 1996; Van Ryk and Venkatesan, 1999). Multimerization then 
stimulates binding of the nuclear export factor Crm1 (also called Exportin) that binds 
a nuclear export sequence (NES) present towards the Rev C-terminus (Fornerod et al., 
1997; Fukuda et al., 1997) (Figure 1).  This transport complex, stabilized by the 
binding of the Ras-like nuclear GTPase Ran bound to GTP (Fukuda et al., 1997), is 
exported into the cytoplasm via nuclear pore complexes through interactions with 
Nup214 and Nup98 (Fornerod et al., 1997; Zolotukhin and Felber 1999).  
Rev Structure 
 To better understand the mechanism of Rev structure and facilitate 
development of antiviral therapies that target Rev function, many labs have attempted 
to determine Rev’s tertiary structure. The structure is not completely known largely 
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due to Rev’s tendency to aggregate and precipitate precluding structural studies 
(Heaphy et al., 1991; Wingfield et al., 1991; Watts et al., 1998). Purified Rev protein 
polymerizes into filaments 8 nm in diameter when incubated with RRE at 40-160 
µg/mL (Wingfield et al., 1991). At 0°C in the absence of RRE, Rev polymerizes into  
hollow filaments 20 nm in diameter with a 5-7 nm diameter axial channel, as viewed 
by standard TEM (Heaphy et al., 1991; Wingfield et al., 1991). Higher resolution 
STEM analyses show Rev filaments are a six-start helix with 31 dimers in two turns 
(Watts et al., 1998). Within the filaments, the Rev dimer has a diameter of 3.2 nm and 
a height of 2.2 nm. The outer and inner filament diameters were approximately 14.8 
nm and 10.4 nm. The outside of the filament appears smooth whereas the inner 
surface has extrusions resembling a ‘top hat.’ (Watts et al., 1998). 
Computer modeling and structural studies that include circular dichroism (CD) 
and solid-state NMR studies reveal the N-terminal half of unliganded Rev assumes a 
helix-loop-helix structure (amino acids 9-24, 25-33, and 34-62, respectively) with 
ARM residing in the second helix (residues 34-62) (Auer et al., 1994; Blanco et al., 
2001) (Figure 2). CD analyses of two C-terminal deletion mutants of Rev, RevΔ68-
112 and RevΔ92-112, show that Rev contains 46-49 residues in α-helical 
conformation in the N-terminus (Auer et al., 1994). Deletion of amino acids 8-26 
from Rev causes significant reduction in helicity and also inhibits Rev’s ability to 
distinguish between RRE and non-specific RNA by 50-fold (Auer et al., 1994). 
Conversely residues 75-93 are 40% β-sheet and less than 20% α-helical in nature. 
Using Raman spectroscopy, the N-terminus of Rev was found to be α-helical with the 
helices oriented in alignment with the longitudinal filament axis (Watts et al., 1998).  
Using solid state NMR, Blanco et al. (2001) found backbone dihedral angles between 
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residues Leu13 and Val16 and residues Arg39, 42, 43, and 44 are consistent with the 
presence of α-helixes.  
 Havlin et al. (2007) using transmission electron microscopy, atomic force 
microscopy and solid state NMR examined the secondary structure of Rev when it is 
bound to 45 bp of SLIIB. Intriguingly, although the morphology of Rev filaments 
change when it is bound to the RRE (Wingfield et al., 1991; Havlin et al., 2007), the 
tertiary structure of Rev does not change detectibly (Havlin et al., 2007).  
Structural basis of Rev-RRE interactions 
 The first glimpse of Rev-RRE structure came when Battiste et al. (1996) used 
solution NMR to examine the complex formed between residues 34-50 of Rev and 
SLIIB. Their analyses confirm these amino acids assume a helical conformation. They 
showed that Asn40 and Arg44 interact with the nucleotides U45, G46, G47, and A73 
in the major groove of the RRE. Arginines at positions 38, 41-43, 46 and 48 also 
make hydrogen bonds and/or electrostatic interactions with the phosphate backbone 
of the RRE. Thr34 that forms hydrogen bonds with G47 further stabilizes these 
interactions. Arginines 46, 48 and 50 appear to make van der Waal and electrostatic 
contacts that orient the C-terminal helix in the major groove of the RRE (Battiste et 
al., 1996). 
 Various groups have conducted mutational analyses and studied the role of 
ARM in Rev-RRE interactions. For example, Belasco et al. (1996) created an 
expression vector where lacZ coding sequences were fused to an RRE such that 
expression of β-galactosidase was dependent upon Rev function through RRE.  By 
placing point mutations in the RRE-LacZ or Rev expression constructs, they were 
able to identify nucleotides and amino acids important for Rev function, respectively. 
They proposed Rev makes multiple contacts with the RRE.  Gln36, Gln51, Asn40, 
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Glu47 of ARM are buried in the major groove of the SLIIB. Asn40 contacts the 
SLIIB, and Glu47 and Gln51 of ARM lie close to the phosphodiester backbone of the 
SLIIB. The series of arginines (34, 35, 38, 39, and 44) were postulated to be 
accessible for direct interaction with the RNA.  
 Mutating individual arginines in the ARM does not affect Rev’s ability to bind 
RRE or localize in the nucleus suggesting that deletion of four arginines in the M6 
may create a change in the conformation of ARM that prevents it from binding the 
RRE (Hammerschmid et al., 1994) (Table 1). Alternatively, the deletion of these four 
arginines as a whole may create a critical loss of electrostatic interactions with 
phosphate backbone of RRE as these residues form a part of residues that establish 
electrostatic contact with the RRE backbone as proposed by Battiste et al. (1996). 
 The ARM also contains the nuclear localization sequences (NLS) (Malim and 
Pollard, 1998; Hope, T.J., 1999). The NLS interacts with importin β that targets Rev 
to the nucleus (Truant and Cullen, 1999). The presence of NLS along with the C-
terminal NES confers Rev the ability to shuttle in and out of nucleus. Because the 
RRE and importin β binding sites are overlapping, Rev bound to RRE can only 
exported. Rev cannot be imported into the nucleus until the RRE dissociates thus 
preventing the re-import of RRE mRNA back in the nucleus. Whereas most ARM 
mutations affect both import and RRE binding, mutating Trp45 affects import and not 
RRE binding (Hammerschmid et al., 1994).  
Rev multimerization 
 Many labs have found a correlation between the extent of multimerization on 
the RRE as detected by EMSA and the extent that RRE-containing transcripts are 
translated (Malim et al., 1989, Cook et al, 1991; Daly et al, 1993). Earliest evidence 
of Rev multimerization were obtained by Malim et al. (1989) who identified 
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mutations that inhibited Rev function without inhibiting RRE binding. One of these 
harbored mutation in the NES (Rev M10). EMSA’s revealed the other two mutants, 
M4 and M7, were unable to form multimeric structures on the RRE. They co-
transfected Tat expression vector along with wild-type Rev, M4, M7 and M10 in COS 
cells. They observed Tat expressed as a truncated 72 amino acid protein in the 
presence of wild-type Rev, showing that wild-type Rev was exporting partially 
spliced Tat mRNA to the cytoplasm. They however observed expression of a full-
length 86 amino acid Tat protein in the presence of M4, M7 and M10 showing they 
are unable to export unspliced RNAs. Subsequent proviral rescue experiments found 
that wild-type Rev and not M4, M7 and M10 was able to rescue Rev deficient HIV 
replication in COS cells, further suggesting the importance of mutated residues in 
Rev’s function (Malim et al., 1989).  
Subsequent mutational analyses refined the requirement of two 
multimerization motifs to residues 12-34 (multimerization motif-1) and residues 51-
63 (multimerization motif-2, Figure 2) (Malim et al., 1989, Auer et al., 1994; Thomas 
et al., 1997). Both are rich in hydrophobic residues and are a part of the N-terminal 
helix-loop-helix domain (Figure 2) (Auer et al., 1994, Thomas et al., 1998, Blanco et 
al., 2001). Thomas et al. (1998) transfected a Rev-dependent expression plasmid into 
cells expressing Rev to measure the ability of different multimerization mutants to 
trans-activate expression of a reporter gene. This reporter plasmid encodes gene for 
chloramphenicol acetyltransferase (CAT) fused to the RRE and is positioned within 
an intron. In the presence of Rev activity, the CAT-RRE transcript will be exported 
before the CAT coding sequences are spliced out. Using this strategy they found that 
amino acids Ala15, Val16, Leu18, Ile19, and Leu22 in multimerization motif-I and 
residues Ile52, Ile59, and Leu60 in multimerization motif-II are critical for Rev 
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function. They predicted that the two helices bind each other and residues 12-23 in 
helix-1 and Ile52, 55 and 59 in helix-2 form a hydrophobic patch creating a site able 
to bind a second Rev monomoer (Thomas et al., 1997). This model is supported by 
Jensen et al. (1997). They digested Rev with different proteases and used radiolabeled 
monoclonal antibodies with defined binding sites to map antigenic sites. By 
comparing protein footprints, they showed that Rev N- and C-termini must lie close to 
each other.  
Although many mutants that inhibit multimerization on the RRE have been 
identified, two mutations have be extensively studied: M4 and M7 (Table 1; Malim et 
al., 1989, Daly et al., 1995; Thomas et al., 1998; Brice et al., 1999). Malim et al. 
(1991) compared the ability of multimerization mutants M4 and M7 with wild-type 
Rev to bind radiolabelled RRE. The results of EMSA’s demonstrated that M4 and M7 
were unable to form the characteristic high molecular weight complexes normally 
formed by wild-type Rev suggesting that M4 and M7 are deficient in multimerization. 
Brice et al. (1999) attributed the deficiency of Rev M7 in multimerization to 
significant structural disruptions introduced due to double deletions. M4 was found to 
be defective in forming higher order multimers due to localized structural changes 
(Brice et al., 1999). Daly et al. (1993) demonstrated that Rev-RRE complex consists 
of at least 2-8 Rev molecules at equilibrium. Moreover, complexes of two or more 
Rev monomers dissociate from RRE less readily than a single bound monomer 
suggesting that binding of two or more Rev molecules stabilizes Rev-RRE 
complexes. These results are confirmed by findings of Charpentier et al. (1997) who 
used dimethyl sulfate (DMS) to study Rev binding sites. DMS methylates the 
nitrogen bases of RNA molecules. In turn, methylation can be detected by primer 
extension during PCR. Methylation is prevented by protein bound to RNA and thus 
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can be used to detect the region in RRE where Rev binds. Peterson and Feigon (1996) 
have demonstrated that binding of 28 amino acids of ARM causes the change in 
conformation of backbone of the high-affinity binding site in RRE. This was 
confirmed by the findings of Charpentier et al. (1997) who found that binding by two 
Rev monomers induces a conformation change in RRE that facilitates Rev 
oligomerization in vivo.  
 Belasco et al. (2001) used a different strategy to investigate multimerization. 
Two Rev binding sites were introduced upstream of the ribosome binding site (RBS) 
of lacZ reporter containing the single copy of wild-type RRE SLIIB. The second of 
the two Rev binding sites, adjacent to the RBS was mutated in a way that it could not 
bind Rev. The logic of this design is that if Rev binds the Rev binding site upstream 
and mutimerizes, it will interfere with the binding of ribosome to the reporter mRNA 
and prevent its translation. Using this strategy, they found residues Val16, Leu18, 
Ile19, and Leu22 and residues Arg48, Gln50, Ile52, Ile55, Ile59, and Leu60 are 
important for Rev multimerzation on RRE. 
 Van Ryk and Venkatesan (1999) used SPR to measure Rev-RRE interactions. 
RRE was adhered to the sensor chip and Rev flowed over the chip. Through the use of 
different length of RRE and different titrations of Rev, their results demonstrated that 
Rev-RRE binding was partially cooperative and that multimerization was not a 
prerequisite for binding. In contrast to the findings of Daly et al. (1993), Van Ryk and 
Venkatesan (1999) also demonstrated that the C-terminus was not required for 
multimerization. Deletion of residues 87-116 did not affect the binding to the 
truncated form of RRE (containing the high affinity SLIIB) and bound with same 
affinity as wild-type Rev. Further, Daugherty et al. (2008) have characterized an 
additional site stem IA on RRE where oligomerization is inhibited by mutations 
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R41A, R42A and W45A. They summarized that Rev uses a combination of binding 
modes (binding to Stem IIB, Stem IA) to bind RRE.  
In an effort to show the importance of multimerization of Rev in vivo, Madore 
et al. (1994) developed a reporter assay similar to two-hybrid system where CAT 
expression is dependent upon Rev oligomerization. The reporter assay consisted of a 
CAT indicator gene fused to high affinity Rev binding site-SLIIB. Their results 
demonstrated that Rev multimerization occurs in vivo. Both the M4 and M7 mutations 
inhibited CAT expression although to different extents. M4 stimulated CAT 
expression that was only 40% of wild-type Rev levels, M7 retained only 10% ability. 
Both mutants were concluded to be multimerization deficient. 
Jain and Bellasco (2001) were able to differentiate between three classes of 
mutants based on their varying ability to multimerize on RRE in gel retardation 
assays. Class one mutants bind the RRE as monomers but are defective in forming 
dimers and higher order multimers. For example, mutating amino acids 18 or 55 did 
not affect the Kd of the Rev monomer to bind the RRE but reduced the affinity for 
dimer binding 10-fold. Class two mutants readily form dimers but show reduced 
higher order multimerization. Class three mutants show defects in all stages of RRE 
binding which were concluded to be structurally defective. Trikha et al. (2005) used a 
reporter construct (HIV envelope derived reporter under CMV early promoter) and 
demonstrated that trimerization defective mutants (class two mutants)  (L12E, V16D, 
L60R; Belasco et al., 2001) were deficient in nuclear export of reporter construct 
showing multimerization is essential for nuclear export in vivo. 
 Daelmans et al., (2004) used FRET and FRAP to show Rev multimerization 
occurs in both the cytoplasm and nucleus. They observed FRET interactions between 
cytoplasmic mutants fused to GFP and BFP and observed FRET in cytoplasm.  They 
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also observed localization of Rev M5-GFP in the nucleus when expressed with wild-
type Rev-BFP construct confirming Rev multimerization in vivo and that ability to 
multimerize does not rely on presence of ARM.  
Rev-tubulin interactions 
 Rev has the propensity to form long filaments in vitro that despite 
retaining the ability to bind RNA, have the tendency to aggregate (Heaphy et al., 
1991; Wingfield et al., 1991). These filaments can be depolymerized by polyanions 
such as poly-G, poly-dG and poly-glutamate suggesting that Rev may be solubilized 
in an negatively charged environment. In an attempt to find the solution conditions 
that allow determination of Rev’s structure, Watts et al. (2000) reasoned tubulin an 
ideal candidate for structural studies. Tubulin is acidic 50 kDa protein with a C-
terminal poly-glutamate tail (also known as E-hooks) exposed on the surface. To 
determine the solution conditions needed to study Rev structure, they found that Rev 
depolymerized MTs into bilayered ring like structures called Rev-tubulin toroids 
(RTTs). The RTTs are also formed with colchicine treated tubulin heterodimers. 
RTTs are 3-4 MDa in molecular weight and have a mean outer diameter of 47 nm. 
STEM analyses suggested that tubulin lines the outside of RTT with Rev lining the 
inside. The apparent stoichiometry of Rev and tubulin is 1:1. 
 The interaction between Rev and tubulin is specific as RTTs form when Rev 
is mixed with rat or bovine tubulin. RTTs do not form when tubulin is incubated with 
other basic proteins like histones, lysozyme and poly-lysine. RTTs are stable and 
unaffected by changes in pH (6-8) and temperature (4 °C and 25 °C). RTT formation 
is unaffected at salt concentration as high as 200 mM. The formation of RTTs 
requires Mg++ ions. In the presence of chelating agents, Rev still depolymerizes MTs 
but RTTs do not form.  Instead, a soluble ≈110 kDa complex corresponding to one 
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Rev monomer and one tubulin heterodimer forms. RTTs also form with tubulin 
treated with subtilisin, protease that cleaves the C-terminal polyglutamate tail of 
tubulin, showing that Rev-MT interactions are not limited to simple electrostatic 
interactions. RTT formation occurred with both taxol stabilized MTs and colchicine 
treated heterodimers suggesting Rev’s ability to recognize specific surface exposed 
residues of tubulin. It also suggests that the binding site for Rev is different from taxol 
and colchicine binding sites.  RTT formation is however blocked when tubulin dimers 
are preincubated with the antimitotic drug maytansine. Since maytansine is known to 
bind β-tubulin at or near the vinca site (Sackett, 1995), it is likely that Rev is 
interacting with β-tubulin near the GTP binding pocket. The ability to depolymerize 
MTs resides in the N-terminal half of Rev as RTTs still form when the first 59 amino 
acids are mixed MTs polymerized with GTP. The ring formation by first 59 amino 
acids of Rev is inhibited with taxol stabilized MTs. Only short polymeric tubulin arcs 
form suggesting that the C-terminus is also important for RTT stabilization (Watts et 
al., 2000).  
A mechanism that explains Rev-tubulin interactions is suggested by the 
presence of a limited sequence similarity between the ARM of Rev and the catalytic 
motor domain of MCAK, a potent MT depolymerase and a member of Kinesin-13 
group of proteins (Watts et al., 2000; Figure 2). Rev residues Thr34, Arg39, and 
Arg42 are shared with MCAK residues Thr506, Arg511, and Arg514 and are thought 
to be surface exposed in both proteins. In Rev, they are important for RRE binding 
(Battiste et al., 1996). The MCAK residues are vital for MT binding (Ogawa et al., 
2004). Hydrophobic residues Ile52, 55, and 59 that are important for interaction 
between helix-1 and 2 in Rev (Thomas et al., 1997) are similar to corresponding 
residues in MCAK (Figure 2B) which reside in a helical structure (α4 helix) and are 
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important for binding and depolymerization (Neiderstrasser et al., 2001; Shipley et 
al., 2004; Ogawa et al., 2004). The α4 helix is thought to bind the intradimer interface 
of the MT (Ogawa et al., 2004).  
Using the program HEX to model the interactions between tubulin 
heterodimers and the ARM peptide (PDB# 1ETF), the ARM is also proposed to bind 
tubulin heterodimers at the α and β-tubulin interface (Deacon Sweeney, pers. comm.). 
This prediction is consistent with the hypothesis that Rev binds the vinca 
(Maytansine) site of tubulin. This region of similarity also includes a part of helix-2 of 
the helix-loop-helix model proposed for the N- terminus for Rev.  
Rev’s ARM may mimic MCAK in several additional ways because MCAK 
has two positively charged regions in addition to the Rev-share sequences 
(Neiderstrasser et al., 2002; Ogawa et al., 2004). One of these regions is called the 
neck that lies adjacent to the motor domain.  In motile kinesins, the neck confers 
motor processivity and directionality. In Kinesin-13s, the neck is rich in positively 
charged amino acids and is proposed to disrupt lateral interactions between adjacent 
protofilaments in a MT during depolymerization (Ogawa et al., 2004).  The second 
basic region is loop L8 that is important for MT binding (Niederstrasser et al., 2002). 
MCAK and MT depolymerization 
MCAK is the best characterized member of Kinesin-13 family and plays an 
essential role in spindle formation and chromosomal movement during mitosis 
(Maney et al., 1998, Ovechina et al., 2002, Kline-Smith et al., 2004). It consists of 
three separate domains: an N-terminal domain that targets kinetochores (Maney et al., 
1998, Wordeman et al., 1999), a middle catalytic core preceded by the neck that is 
essential for MT depolymerization (Maney et al., 2001, Ogawa et al., 2004), and a C-
terminal tail that regulates dimerization and ATPase activity (Maney et al., 2001). 
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Maney et al. (2001) and Hertzer et al. (2006) have proposed that the MCAK 
monomer forms the minimal active unit but the dimer depolymerizes MTs three-fold 
more efficiently. Neiderstrasser et al. (2002) showed that MCAK acts on a single 
protofilament because it is able to depolymerize zinc polymerized tubulin, tubulin 
sheets made of anti-parallel protofilaments.  
The positively charged neck of MCAK is proposed to act as electrostatic 
tether by interacting with negatively C-terminus of tubulin making MT 
depolymerization efficient (Maney et al., 2001; Ovechina et al., 2002). C-terminal E-
hooks of MTs are also required although they are dispensable for binding MCAK 
(Neiderstrasser et al., 2002). Limited digestion by protease subtilisin that cleaves E-
hooks of tubulin shows that the C-terminal domain of β-tubulin is essential for 
microtubule depolymerization (Moores et al., 2002; Neiderstrasser et al., 2002). 
Moores et al. (2002) further proposed a model of depolymerization of microtubules 
wherein the motor core of pKinI (MCAK homolog in Plasmodium falciparum) binds 
to the ends of the microtubules with the subsequent release of ADP. The release if 
ADP leads to the binding of ATP that causes a bend in the tubulin dimer. This 
conformation change causes release of the dimer from the protofilament, followed by 
the dissociation of the motor core and tubulin with the subsequent hydrolysis of ATP 
(Moores et al., 2002, Niederstrasser et al., 2002). 
A comparison of the molecular structure of ADP bound form of Kif2C 
(murine ortholog of MCAK) and Kif1A (a motile kinesin) shows several differences 
in the following seven regions that are well conserved in Kinesin-13 group (Ogawa et 
al., 2004).  Six of these regions (L2, α2-L5, L8-α3-L9, L10, L11-α4-L12, α6) form a 
part of the characteristic, conserved motor domain of Kinesin-13 group of proteins, 
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the seventh being the neck region. Two of these regions, loop L8 and α4 helix, are 
shared with Rev (Ogawa et al., 2004). 
The Loop L2 in Kif2C has a characteristic ‘KVD’ motif (Lys293, Val294, 
Asp295) that forms a long, rigid finger like projection. This motif is appreciably 
smaller in Kif1A and mutation in this region reduces MT depolymerization 
significantly in Kif2C. The L5 loop is larger in Kif2C than Kif1A and is conserved in 
various members of Kinesin-13 family. The C-terminus of α2 helix is kinked at 
Pro384 in Kif2C. The longer L5 and kinked α2b displace the main α2 helix by 10° in 
clockwise direction. This results in likewise rotation in following α3 helix that further 
results in change in positions of Loop L8 (lysine-arginine loop), which is proposed to 
serve as a sensor for regulation of ATP hydrolysis, and L9. Residues Asp502-Arg 506 
at the end of L11 are wound up in α4 helix (the main MT binding region, Rev 
homology region), which make α4 helix longer in Kif2C and tilts it 5° compared to 
Kif1A.  
X-ray chrystallographic studies and in silico modeling suggests that the class 
specific residues at the end of α4 helix of the motor domain of Kif-2C binds the 
curved MT end and link the poly-glutamate tail of β-tubulin with α-tubulin (Ogawa et 
al., 2004). The crosslinking of the poly-glutamate tails of the α- and β-tubulin 
stabilizes the curved structure of the intradimer interface and causes the initiation of 
ATP hydrolysis in Kif2C. Crosslinking also facilitates the insertion of KVD finger 
(absent in motile kinesins) in the interdimer interface and stabilizes the curved 
conformation of the protofilament. Mutating KVD impairs MCAK’s ability to 
depolymerize MTs (Shipley et al., 2004). The N-terminal region buries between 
protofilaments thus destabilizing the lateral interaction between of the protofilaments 
(Ogawa et al. (2004). Shipley et al. (2004) have also suggested that loop L11 and L2, 
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on the either side of motor core of pKinI form the anchor points on MTs. They have 
further suggested that mutating the KEC residues of the α4 helix inhibits MCAK’s 
ability to depolymerize MTs (Shipley et al., 2004). Mutating the ‘E’ residue of KEC 
in the α4 helix inhibited MCAK-MT binding (Ems-McClung et al., 2007). Rev also 
has a conserved ‘E’ at position 57 similar to the ‘E’ residue of KEC, and this E57 in 
Rev also forms a part of helix-2 in Rev, suggesting that E57 might be playing an 
important role in MT interaction.  
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MODEL AND SPECIFIC AIMS 
Any model that explains Rev-tubulin interactions must provide a mechanism 
that explains how Rev binds the MTs, how MT ends are peeled from the MT polymer, 
and ultimately how RTTs form.   
Binding: There are several possible explanations explaining how Rev is able to bind 
MTs.  The simplest explanation of electrostatic interactions between the ARM and E-
hooks seems unlikely given the observation that RTT formation occurs even when the 
E-hooks are removed by subtilisin treatment (Watts et al., 2000). The primary binding 
determinants must reside with the N-terminal 59 residues of Rev that can still form 
RTTs. These 59 residues includes the helix-loop-helix motif, the ARM and both 
multimerization domains as well as sequences shared with Kinesin-13 depolymerases 
(Watts et al., 2000; Neiderstrasser et al., 2002). Both the motor domain of Kinesin-13 
proteins and ARM of Rev have been proposed to bind at the intradimer interface of 
MTs further supporting similar binding mechanism (Deacon Sweeney, per.comm.; 
Ogawa et al., 2004). The shared sequences and secondary structures of Rev and motor 
domain of Kinesin-13 protein raise the possibility of ARM of Rev involved in MT 
binding.  
Considering the similarities between Rev’s ARM and Kinesin-13 proteins, 
Rev may be interacting with MTs in a manner similar to Kinesin-13-MT interaction. 
Rev’s ARM may mimic the neck of Kinesin-13 proteins that is also rich in positively 
charged residues, regulates MT binding and is essential for MT depolymerization by 
disrupting of lateral interactions between protofilaments. It is also a possibility that 
Rev’s ARM may be acting like MT binding Loop-8 of MCAK thus aiding in 
establishment of mutiple contacts on MTs.  
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Depolymerization: MCAK has three distinct positively charged regions that help in 
MT depolymerization. The positively charged neck region helps in disrupting the 
lateral interactions between the MT protofilaments at MT ends (Ogawa et al., 2004). 
Rev’s ARM may behave similarly. The ARM may also act like the α4 helix of the 
catalytic domain of MCAK. The α4 helix is suggested to stabilize the curved 
conformation of MT ends (residues 268-270, 272). Since Rev shares the sequence 
similarity with this region of MCAK, there is a possibility that Rev’s ARM may be 
acting in a similar manner. The similarities include but are not limited to Arg514 of 
MCAK, which is similar to Arg42 of ARM of Rev, which is mutated in M6. Another 
residue, Glu530, which when mutated in MCAK, inhibits its ability to depolymerize 
MT. Rev has a similar residue at position 57, suggesting that this amino acid may be 
participating in Rev’s interaction with MTs. Similar possibilities exist for other shared 
residues mentioned in Figure 2B, supporting the possibility of similarity in 
mechanism for Rev-MT interactions. The third possibility is that Rev’s ARM may be 
acting like the Lys-Arg loop of MCAK, involved in binding MTs (Ogawa et al., 
2004). During MT depolymerization when MCAK binds the MT ends, the neck 
region causes the disruption of lateral interaction between the protofilaments, loop L8 
in the Lys-Arg loop region causes the hydrolysis of ATP while the α4 helix causes the 
stabilization of the curved conformation of MT ends. Rev might be acting in a similar 
way wherein the multimerizing Rev induces the curved conformation of MT ends and 
the ARM may act like neck or the α4 helix (the two positively charged regions of 
MCAK) to cause MT depolymerization. 
RTT Formation: Watts et al. (2000) suggest that Rev causes MTs to peel outward 
forming RTTs. The formation of RTTs by outward peeling of MTs is consistent with 
tubulin lining the outside and Rev lining the inside of RTTs. During the formation the 
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RTT, it is possible that Rev binds the lattice, multimerizes on it and as it reaches the 
ends, it exerts an outward bending force needed to peels the protofilament from the 
MTs, like peeling a banana. Alternatively, it is possible that multiple Rev monomers 
bind the lattice first, multimerize until the MT end is reached, and MTs peel into 
rings. In either case, Rev multimerization provides multiple contacts on the surface of 
the MT and has the potential to generate a ripping/bending force required to make an 
RTT.  
The formation of bilayered rings suggests that Rev may act upon two MT 
protofilaments at a time although it is formally possible that single layered rings form 
first that subsequently join. The second of the above two possibilities is supported by 
the fact that RTTs also form with tubulin heterodimers. The possibilities mentioned 
above support the idea that there might be a lateral interaction (dimerization) between 
Rev molecules in adjacent layers in a bilayered RTT.  
Dimensional Considerations in an RTT: Watts et al. (2000) proposed a model of 
RTT in which 15 tubulin heterodimers lining the outside of the ring and 30 Rev 
monomers line the inside.  The width of a tubulin monomer (4.3 nm) agrees well with 
the spacing of tubulin seen in the outer rim of RTT (Watts et al., 2000). The inner rim 
of the ring had a spacing of 3.3 nm, consistent with the size of Rev dimers present in 
the Rev filaments (Watts et al. (1998). The above findings that the inner rim in an 
RTT has a spacing of 3.3 nm and that the width of a Rev dimer is 3.2 nm suggests that 
Rev may be binding tubulin heterodimers as a dimer  (Figure 3). Since the diameter of 
the base of the ‘Top Hat’ is not sufficient (3.2 nm of Rev dimer as compared to 8 nm 
of a tubulin heterodimer) to interact with the adjacent Rev dimer (multimerization), 
the bound Rev dimer might introduce additional bends in the conformation of the 
heterodimer. There is also a possibility that the adjacent Rev dimer do not interact 
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with each other in the same layer (this could be due to limited ability of heterodimer 
to curve) but interact with the Rev dimer of the neighboring layer thus further aiding 
in formation of a bilayer (Figure 3).  
Specific Aims 
Rev and Kinesin-13 proteins share more than a sequence similarity.  Both 
depolymerize MTs (Watts et al., 2000; Desai et al., 1999). Both form rings when 
mixed with MTs (Watts et al., 2000; Desai et al., 1999; Moores et al., 2002). 
Moreover, like Rev, MCAK homo-oligomerizes albeit it is only a dimer.  Dimeric 
MCAK is a more potent depolymerase than the monomer by a factor of three (Hertzer 
et al., 2006). Since Rev is also capable of multimerizing, I tested the hypothesis that 
Rev multimerization is important for MT depolymerization. To test this 
hypothesis, I compared and contrasted the ability of the multimerization defective 
mutant M4 form RTTs and depolymerize MTs to the wild-type protein using assays 
commonly used to monitor Kinesin-13 activity. 
  I have also tested the hypothesis that residues 41-44 in the ARM are 
important for Rev- MT interactions. Residues 41-44 are critical for RRE binding 
and comprise a part of Rev-Kinesin-13 shared region.  For these experiments, I will 
compare the M6 mutant with wild-type Rev for its ability to depolymerize MTs and 
form RTTs. Mutation in M6 includes Arg42 that is similar to critical residue Arg514 
that lies in MT binding region of MCAK. Inability of M6 to interact with tubulin will 
show that residues 41-44 form a minimum region in Rev responsible for binding and 
depolymerization. Conversely, formation of any kind of complex, determined by 
combination of sedimenation assays, gel filtration assays and electron microscopy, 
will suggest the role of other shared residues in ARM. Taken together, I  
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Figure 3: Proposed spatial arrangement of Rev and tubulin in RTT. A) Rev binds 
the intradimer interface of tubulin as a dimer. The interaction between adjacent Rev 
dimer (top hat) on the tubulin intradimer interface creates a force required for 
introducing the curved conformation in the terminal heterodimer in a MT and cause 
depolymerization. B) Alternatively, Rev bound to one tubulin heterodimer may 
multimerize with a Rev dimer bound to diagonally opposite heterodimer on the 
neighboring protofilament, together generating the force required for MT peeling and 
RTT formation. 
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have tested the above hypothesis by performing experiments that test whether 
residues 23, 25 and 26 are required for binding tubulin heterodimers and forming 
RTTs. I have also performed experiments that test the importance of these residues in 
MT depolymerization. 
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MATERIALS AND METHODS 
Rev purification 
Rev and mutants: The plasmid pET11D-Rev encoding wild-type Rev was kindly 
provided by Dr. Blanco (Blanco et al., 2001). Point mutations were introduced in the 
wild-type gene using the Quikchange Site Directed Mutagenesis Kit (Stratagene Inc., 
CA), using primers listed in Appendix A and confirmed by double stranded 
sequencing (Davis Sequencing, Davis CA). The wild-type and mutant plasmids were 
perpetuated in E.coli DH5α cells and stored in 15% glycerol stocks at -80°C.  
To express Rev, BL21(DE3) cells were transformed with Rev expression 
plasmids that were grown and selected on Luria-Bertini (LB) agar plates 
supplemented with 50 µg/ml ampicillin. Large scale 1 L LB/amp cultures were 
inoculated with 50 ml overnight cultures initiated from a single colony from a plate 
stock.  All cultures were grown at 37°C with 250 rpm shaking. Expression of Rev was 
induced with the addition of 1 mM IPTG when cultures exhibited exponential growth 
(OD600≈0.6). Two hours later, cells were harvested by centrifugation at 5,000 x g for 
10 min.  Cell pellets were frozen at -80ºC until Rev was purified.  
Purification:  Cell pellets were resuspended in a buffer A (50mM Tris-HCl pH 8.0, 1 
mM DTT, 1 mM EDTA, and 5 mM PMSF) supplemented with 400 mM NaCl and 
lysed by sonication, three 30 s pulses at 10 w. Sonicates were frozen at -80ºC for five 
minutes, quickly thawed and sonicated as before. Sonicates were clarified by 
centrifugation at 12,000 x g for 10 min in a SS34 rotor (Sorvall, CA) and FPLC 
purified using the methods of Karn et al. (1995). Briefly, lysates were fractionated 
using a Q-Sepharose column (GE Life Sciences, NJ). The column was washed with 
buffer A plus 400 mM NaCl and Rev-RNA complexes were eluted with buffer B 
(Buffer A plus 800 mM NaCl). The eluate was collected and fractioned using a 
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Heparin-Sepharose column (GE life sciences, NJ).  The column was washed with five 
column volumes of buffer B followed by five column volumes of buffer C (Buffer A 
plus 1 M NaCl). Rev was eluted with buffer D (Buffer A plus 2 M NaCl). The 
presence of Rev was confirmed by immunodetection using Rev specific antibodies 
and the purity confirmed by SDS-PAGE and coomassie brilliant blue staining. Figure 
4 shows representative results of purification. 
Rev obtained from heparin-sepharose chromatography was monomeric owing 
to the high salt concentration (2 M) that must be diluted before mixed with MTs. MTs 
depolymerize in 500 mM salt (Mendez, 1998).  However, because Rev aggregates 
under low salt conditions (Wingfield et al., 1991, Watts et al., 2000), purified Rev 
was denatured and refolded into filaments using the methods of Watts et al. (1998) 
and concentrated by ultrafiltration (Centricon-30) or ultracentrifugaton (320,000 x g, 
4 hours, in a TLA100 rotor). Protein concentrations were determined 
spectrophotometrically (ε=8.31 mM-1cm-1) and by densitometric scanning of 
coomassie stained proteins relative to BSA standards resolved by SDS-PAGE using 
ImageJ (Rasband, 1997-2007).  
Alternatively, wild-type and M4 were also purified with an alternative 
modified protocol derived from Wingfield et al. (1991). In the modified protocol the 
DEAE-sepharose and Fast S columns are substituted with Q-sepharose and heparin-
sepharose columns, respectively. Rev-expressing cell pellets from 1 L cultures of E. 
coli were sonicated as above in lysis buffer (0.1 M Tris-HCl, pH 8.0, 5 mM DTT, 
5mM PMSF, 5mM benzamidine and 5 mM EDTA). Sonicates were subjected to 
10,000 x g centrifugation for 10 min. The supernatant was collected and further 
subjected to a spin at 60,000 x g for one hour. The supernatant was collected and 
diluted 3 fold in buffer containing 50 mM Tris-HCl, pH 8.0, 1 mM sodium azide and 
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applied over Q-sepharose column. Rev eluted in the flow-through fractions, which 
were collected and supplemented adjusted to 6.5 using phosphoric acid. The Rev 
containing solution was then applied over with solid urea to a final concentration of 6 
M. The resultant solution was diluted in buffer E (0.02 M sodium phosphate, pH 6.5, 
1 mM EDTA, 1mM DTT and 2 M urea) and pH heparin-sepharose column. The 
column was then washed with buffer E which was followed by application of a five 
column volume gradient of NaCl (0-1 M) in buffer E. Rev elutes off at 0.5 M NaCl 
which was than subjected to refolding and concentration determination as described 
above.   
M6 purification: Rev purified using the above methods relies on the ability of Rev to 
bind cellular RNA which then binds the Q-sepharose column. This complex is then 
dissociated by high salt and Rev is purified exploiting its affinity for heparin. 
However, this procedure does not work well for M6 that has reduced affinities for 
RNA and heparin. To purify M6, I used a modified protocol derived from Wingfield 
et al. (1991). Bacterial cell lysates clarified by 60,000 x g centrifugation were 
introduced over Q-Sepharose column under no salt conditions (0.1 M Tris-HCl, pH 
8.0, 5 mM DTT, 5mM PMSF, 5mM benzamidine and 5 mM EDTA). The absence of 
salt allows for limited Rev aggregation, which elutes off separating it from nucleic 
acids (bound to the column). Rev, present in the flow-through, is denatured in 6 M 
urea, and subjected to refolding as described above in the Rev purification section.  
Since M6cannot be completely purified, BL21(DE3) E.coli whole cell extracts were 
used as a control.  
Tubulin Purification 
  Tubulin was purified from freshly procured bovine brains according to the 
methods of Walczak and Desai, 2001. Briefly the meninges are stripped and brains 
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were homogenized in Pipes buffer (PB) (0.1 M K-Pipes pH 6.8, 0.5 mM MgCl2, 2 
mM EGTA, 0.1 mM EDTA, 0.1 % β-mercaptoethanol, 1 mM ATP).  The lysate was 
centrifuged at 33,000 x g for 2 hr at 4°C using a GS3 rotor (Sorvall). The supernatant 
was collected and supplemented with 1.5mM ATP, 0.1 mM GTP, 3.5 mM MgCl2 and 
50% glycerol (final concentrations) and incubated at 37°C, 1 hr. The extract was 
subjected to centrifugation at 33,000 x g, 165 min, 35°C. The pellet was recovered, 
resuspended in cold PB, homogenized in presence of additional 1 mM ATP and 0.1% 
β-mercaptoethanol, and incubated at 4°C, 40 min.  The homogenate was subjected to 
centrifugation at 190,000 x g, 30 min, 4°C, in a Beckman type 50.2 Ti rotor and the 
supernatant containing tubulin heterodimers was recovered. The supernatant was 
supplemented with warm 50% glycerol, 0.5 mM GTP and 4 mM MgCl2, at 37°C for 1 
hr.  The extract was centrifuged at 240,000 x g 30 min centrifugation at 35°C, in a 
Beckman type 50.2 Ti rotor. The pellet was resusupend in column buffer (CB) (50 
mM K-Pipes, pH 6.8; 1 mM EGTA; 0.2 mM MgCl2). The pellet was dounce 
homogenized and incubated at 4ºC for 40 min to depolymerize MTs. The supernatant 
was recovered after centrifugation at 190,000 x g, 30 min, 4°C and applied over a 200 
ml phosphocellulose (PC) column equilibrated in CB.  Tubulin present in the flow-
through fractions was collected, pooled and flash frozen in 7 ml aliquots in liquid 
nitrogen (Figure 5). This tubulin was called PC tubulin. A small fraction was used to 
determine the concentration using spectrophotometric (O.D. 280 nm, ε of tubulin 
115,000 M-1cm 1) and densitometric methods using ImageJ and bovine gamma 
globulin as a standard. 
Sedimentation assays 
 Purified tubulin heterodimers were diluted to 3 µM in MEM (100 mM MES, 1 
mM EGTA, 2 mM MgCl2, pH 6.9) on ice for 10 min and clarified by 360,000 x g 
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centrifugation using a TLS optima centrifuge. In some experiments, the supernatant 
was supplemented with 50 µM colchicine (Sigma, St. Louis, MO) and diluted to the 
desired concentration in MEM.  In other experiments, the supernatant was 
supplemented with GMPcPP to 1 mM final concentration and incubated at 37˚C for 
30 min.  Polymerized microtubules were recovered by 360,000 x g, 5 min 
centrifugation at 37˚C and diluted to twice the desired final concentration in MEM.  
Rev was diluted in MES (100 mM MES, 2 mM MgCl2, pH 6.9) to twice the desired 
final concentration (~10 µM) immediately before use. In most instances, MgCl2 was 
added ensuring the final concentration was 1-2 mM above the citrate concentration. 
Reactions were initiated by mixing equal volumes of tubulin or microtubules with 
Rev for prescribed times at room temperature. Samples were subjected to 5 min, 
360,000 x g centrifugation. Pellet and supernatant fractions were recovered and the 
proteins present in each were resolved by SDS-PAGE (Desai and Walczak, 2001).  
Gels were stained with coomassie brilliant blue and the amount of tubulin present in 
each fraction was quantified using ImageJ (Rasband, 1997-2008). In some instances, 
proteins were transferred to nitrocellulose membranes at 50 mV for 1.5 hr in transfer 
buffer (25 mM Tris, pH 8.3, 192 mM glycine, 20% ethanol). Rev and tubulin were 
detected by immunoblotting using protein specific antibodies (sheep anti-Rev, US 
Biologicals, Swampscott, MA; DM1a, Sigma, St. Louis, MO). 
Transmission electron microscopy (TEM) 
Aliquots (5 µl) of mixtures described above were spotted onto a carbon coated 
mica grid (Ted Pella, CA). After 1 min, excess sample was wicked away and the 
sample was fixed with 1% uranyl acetate for 20 s. The sample was stained with 1% 
uranyl acetate for 1 min, air dried and visualized with a Philips EM 208S electron 
microscope at 56000x magnification. 
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Gel filtration chromatography (superdex-200) 
  Mixtures of Rev and colchicine-treated tubulin were resolved on a Superdex-
200 gel filtration column equilibrated with 150 mM sodium phosphate (pH 7.2) and 
50 mM sodium chloride. Aliquots of collected fractions were resolved by SDS-
PAGE, and transferred onto nitrocellulose membranes.  Rev and tubulin were 
detected using protein specific antibodies. 
Statistical Analysis 
 Statistical analysis for data obtained from sedimentation assays involving 
tubulin heterodimers and Rev (in presence and absence of Mg++) was performed using 
one-way ANOVA. When required, Tukey’s HSD posthoc testing was used. 
 Regression model, Bonferroni corrections and students T-test analyzed data 
obtained from sedimentation assays. 
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RESULTS 
Purification of tubulin, wild-type Rev, M4 and M6 
Wild-type Rev, M4 and M6 were over-expressed in BL21(DE3) cells and 
purified using FPLC, as described in “Materials and Methods”.  Presence of Rev was 
confirmed using Rev specific antibodies. Whereas purified wild-type Rev and M4 
were largely devoid of impurities, M6 was not comparably purified because it did not 
bind the heparin column (Figure 4). Despite the impurities, TEM analysis 
demonstrates that wild-type Rev and M6 form similar ≈13 nm filaments, consistent 
with the published work (Figure 5) (Watts et al., 1998). There were no signs of 
filament bundling or aggregation. On the contrary, M4 did not form filaments. Large, 
irregular shaped, high molecular weight complexes were present, consistent with the 
idea that the M4 mutation inhibits Rev-Rev interactions (Figure 5). Tubulin was 
purified from bovine brains, as described in “Materials and Methods” (Figure 6). 
Measuring interactions between wild-type Rev and tubulin heterodimers  
 Sedimentation assays were performed to determine whether Rev binds tubulin 
and forms high molecular weight complexes. These assays are routinely used to 
characterize MCAK-MT interactions (Desai and Walczak, 2001). To compare the 
ability of Rev to interact with tubulin and form high molecular weight complexes, 
different concentrations of Rev were incubated with tubulin for 10 minutes and 
centrifuged at 360,000 x g. In the absence of Rev, tubulin heterodimers fractionate 
into the supernatant following centrifugation. However, with the addition of different 
concentrations of wild-type Rev in the presence of Mg++, significant amounts of 
tubulin fractionates into the pellet (one-way ANOVA; p=0.013). Posthoc test  using 
Tukey’s HSD demonstrates that significant amount of tubulin fractionates in the pellet  
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Figure 4: Rev Purification. Representative results of proteins resolved by SDS-
PAGE. Rev expressed in BL21(DE3) cells were lysed, fractionated (bound and 
eluted) using Q-Sepharose (A) and heparin-sepharose (B). Purified wild-type Rev, 
M4 and M6 used in the experiments are shown in C, D and E respectively. Gels are 
stained with coomassie brilliant blue. The markers in A and B correpond to 180 (top), 
115, 82, 64, 49, 37, 26, 19, 15 and 6 kDa (bottom). The markers in C, D and E 
correpond to 170 (top), 135, 100, 72, 55, 42, 33, 24, 17 and 11 kDa (bottom).  
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Figure 5: Electron micrographs of purified Rev and mutants: A. purified and 
refolded wild-type Rev, B. M4, and C. M6. Magnification bar correspond to 200nm.
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Figure 6: Tubulin Purification. Tubulin was purified as described in materials and 
methods. A representative coomassie stained gel, depicting tubulin (A) separated 
from MAPS (B) after phosphocellulose chromatography.  
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at 1:1 Rev-tubulin heterodimer ratios ( p<0.05). The formation of high-molecular 
weight complexes is consistent with the formation of RTTs (Figure 7). Although not 
statistically significant, more tubulin is detected in the pellet fractions at lower 
concentrations than is seen with the wild-type protein (Figure 7). Sedimentation 
assays further show that compared to no Rev control, product formation takes place at 
1:1 wild-type Rev monomer/tubulin heterodimer molar ratio in the absence of Mg++ 
(one-way ANOVA, p<0.0001) (Figure 7). However, high molecular weight 
complexes were absent below Rev monomer-tubulin ratio of 1:1 (Figure 7).  
The formation of pelletable complex in the absence of Mg++ is contradicts the 
results obtained by Watts et al. (2000). To investigate the formation of pelletable 
products in the absence of Mg++ and to determine the sizes of products formed in the 
absence and presence of Mg++, S200 size exclusion chromatography was performed. 
Size exclusion chromatography provides the advantage of separating high molecular 
weight complexes based on size, with larger complexes eluting out faster whereas the 
smaller ones have to pass through the pores of the chromatography beads. In the 
absence of Rev, colchicine-treated tubulin elutes in fractions 15 corresponding to the 
size of 142 kDa (Figure 8). 500 µl fractions were collected during gel filtration 
chromatography which may explain the calculated size of tubulin heterodimer to be 
142 kDa and not 110 kDa. It is a possibility that collection of smaller fractions may 
provide a better approximation of the size of the tubulin heterodimer.  
The peak in the chromatogram is broad suggesting the presence of oligomers 
of tubulin in addition to heterodimers. When Rev-tubulin heterodimer mixtures in 1:1 
molar ratio were resolved in the absence of Mg++, Rev and tubulin eluted in fractions 
corresponding to ≈142 kDa (Figure 9). The formation of similar-sized complexes in 
the presence and absence of Rev suggest that the experiments in the absence of Mg++  
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Figure 7: Wild-type Rev forms high molecular weight complexes when mixed 
with tubulin heterodimers. A. Coomassie stained gel showing tubulin present in the 
supernatant (S) and pellet fractions (P) after tubulin heterodimers are mixed with 
different concentrations of wild-type Rev in the presence of Mg++. B. Graphical 
representation of the quantification of tubulin heterodimers in the (S) fraction after 
incubation with wild-type Rev, in the presence of Mg++. C. Coomassie stained gel 
showing tubulin present in the (S) and (P) fractions after tubulin heterodimers are 
mixed with different concentrations of wild-type Rev, in the absence of Mg++. D. 
Graphical representation of the quantification of tubulin heterodimers present in the 
(S) fraction after incubation with wild-type Rev, in the absence of Mg++. Black star 
corresponds to p<0.05 (one-way ANOVA, n=15; PostHoc test using Tukey’s HSD); 
Red stars corresponds to p<0.0001 (one-way ANOVA, n=12; PostHoc test using 
Tukey’s HSD). Error bars correspond to standard deviations.
 43 
    A.                                                               C.                                
 
 
 
 
 
B.                                                                        D.   
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                                              
 
 
 44 
Figure 8: Gel filtration of reactions involving Rev and its mutants with tubulin  
in the presence of Mg++. Representative chromatograms from S200 gel filtration 
chromatography (presence of Mg++) and immunoblots detecting tubulin (black arrow) 
and Rev (red arrow) present in the designated fractions for A. Colchicine treated 
tubulin alone, B. Wild-type Rev and colchicine treated tubulin, C. M4 and colchicine 
treated tubulin, and D. M6 and colchicine treated tubulin. Representative 
chromatograms from S200 gel filtration chromatography of gel filtration standards: 
E) Dextran Blue (black arrow, 2 MDa), F) Molecular weight standard proteins 
showing elution peaks for Ferritin (F, 440 kDa), Aldolase (A, 158 kDa), Conalbumin 
(C, 75 kDa) and Ribonuclease A (R, 13.7 kDa). 
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Figure 9: Gel filtration of reactions involving Rev and its mutants with tubulin in 
the absence of MgCl2. Representative chromatograms from S200 gel filtration 
chromatography (absence of Mg++) and immunoblot for Tubulin (black arrow) and 
Rev (red arrow) in corresponding fractions for A. Wild-type Rev and colchicine 
treated tubulin, and B. M4 and colchicine treated tubulin, C. M6 and colchicine 
treated tubulin. 
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need to be performed using gel-filtration column that will facilitate better resolution 
of complexes. The absence of Rev-tubulin complex in the void volume however 
suggests that the pelletable complex detected in the sedimentation assays in the 
absence of Mg++ may be the rings that are unstable and hence not detected during the 
S200 chromatography.  
Chromatography of Rev:tubulin (1:1 molar ratio) mixtures supplemented with 
Mg++ show a significant amount of Rev and tubulin elute in the void volume 
(fractions 9 and 10), corresponding to complexes with sizes greater than Mr≈ 500 kDa 
(Figure 8). The presence of tubulin and Rev in the void volume suggests the 
formation of high molecular weight complex that is consistent with presence of RTT.  
To determine whether the materials in the pellets are RTTs, aliquots of Rev-
tubulin mixtures were spotted on a carbon coated mica grid, stained with 1% uranyl 
acetate, dried and visualized using TEM. RTTs formed at 1:1 molar ratio of Rev 
monomer and tubulin heterodimer (Figure 10). Consistent with the diameter of RTTs 
observed by Watts et al. (2000), the majority of RTTs observed during this study 
were ≈ 40 nm in diameter. 
Taken together these data confirm the results of Watts et al. (2000), validate 
the sedimentation assays and show that Rev used in the study is functional. 
Measuring interactions between M4 and tubulin heterodimers  
Sedimentation assays show that M4 bound tubulin heterodimers significantly 
in the presence of Mg++ in a concentration dependent manner (one-way ANOVA p< 
0.0078) (Figure 11). Post hoc tests performed using Tukey’s HSD demonstrated that 
complex formation was significant at concentrations ≥ 1.5 µM (p<0.05). Although 
M4 appears to sediment more tubulin than the wild-type protein, these differences are 
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Figure 10: Electron micrographs of mixtures of tubulin heterodimers in Rev 
buffer (A), with wild-type Rev (B), M4 (C) and M6 (D): Black, yellow and red 
arrows point to complexes formed with wild-type Rev, M4, and M6, respectively. 
Magnification bar correspond to 200 nm.  
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Figure 11: Sedimentation assays with M4 and tubulin. A. Coomassie stained gel 
showing tubulin concentration in the supernatant (S) and pellet fraction (P) when 
tubulin heterodimers are incubated with varying concentration of M4, in the presence 
of Mg++. B. Graphical representation of the quantification of tubulin heterodimers in 
the (S) fraction after incubation with M4 in the presence of Mg++. C. Coomassie 
stained gel showing tubulin concentration in the (S) and (P) fraction when tubulin 
heterodimers are incubated with varying concentration of M4, in the absence of Mg++. 
D. Graphical representation of the quantification of tubulin heterodimers present in 
the (S) fraction after incubation with M4 in the absence of Mg++. Black stars 
correspond to p=0.05 (one-way anova, n=15; Posthoc test using Tukey’s HSD). Error 
bars correspond to standard deviations. 
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not statistically significant (one-way ANOVA; p=0.8). M4 did not form high 
molecular weight complexes in the absence of Mg++ (one-way ANOVA; p=0.5) 
(Figure 11).  
S200 gel filtration chromatography was performed to investigate the sizes of 
the complex formed by M4. The results in the presence of Mg++ show that similar to 
wild-type Rev, RevM4 formed high molecular weight complexes that elute out in the 
void volume and contain both Rev and tubulin (Figure 8). Elution of tubulin and Rev 
together in fractions 15 and 16 suggests that only low molecular weight complexes 
(consisting of both Rev and tubulin) are observed in the absence of Mg++ (Figure 9).  
TEM analysis in the presence of Mg++ shows that M4 does not form RTTs. 
Instead heterogeneous clusters are seen (Figure 10). Sedimentation assays conducted 
in parallel with TEM show that almost 94% of tubulin shift from the supernatant to 
pellet fraction after incubation with M4 (Figure 12).  
These data collectively argue that the M4 mutation does not block tubulin binding or 
the formation of high molecular weight complex formation. However, it does block 
RTT formation. 
Measuring interactions between wild-type Rev and MTs  
 Previous studies suggest that wild-type Rev depolymerizes GMPCPP 
polymerized MTs into spirals (Watts et al., 2000). GMPCPP is a slowly hydrolysable 
analog of GTP and prevents MT from spontaneously depolymerizing during the 
course of experiments. To compare the abilities of wild-type Rev and M4 to 
depolymerize stabilized MTs, sedimentation assays were conducted. In the absence of 
Rev, stabilized MTs sediment in the pellet fraction after high-speed centrifugation. 
Rev’s effect on MTs can be determined by observing release of tubulin heterodimers  
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Figure 12: Sedimentation assays corresponding TEM of wild-type Rev, M4 with 
tubulin A. Coomassie stained gel showing tubulin present in supernatant (S) and 
pellet (P) fractions in absence of Rev and when tubulin is incubated with wild-type 
Rev and M4, in the presence of Mg++. B. Graphical representation of tubulin in 
supernatant fraction after it is treated with wild-type Rev and M4. C, D, and E. 
Representative electron micrographs of tubulin alone (C), RTT formed in presence of 
wild-type Rev (D) and high molecular weight complex in presence of M4 (E).
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in the supernatant fraction. However, measuring depolymerization is complicated by 
the fact that any tubulin released from MTs may bind Rev and form RTTs (Figure 
10). Since RTTs also fractionate into the pellet, the true amount of tubulin present in 
the supernatant will be underestimated. However, sedimentation assays can be used to 
qualitatively demonstrate MT depolymerization stimulated by Rev addition. 
Sedimentation assays reveal that wild-type Rev releases significant amounts of 
tubulin heterodimers from MTs both in the presence and absence of Mg++ (linear 
regression and Bonferroni correction; p<0.04 and p<0.0001, respectively) (Figure 13). 
Statistical analysis also shows that depolymerization is more significant in the 
absence of Mg++ than in the presence of Mg++ (linear regression and Bonferroni 
correction; p<0.01). More depolymerization in the absence of Mg++ is consistent with 
the finding that the presence of Mg++ promotes high molecular weight complex 
formation that may prevent detection of released tubulin during sedimentation assays 
with Rev and MTs. Even at Rev:tubulin heterodimer stoichiometries of  >1:1, roughly 
50% of the tubulin remained in the pellet suggesting either that  Rev is unable to 
depolymerize all the MTs in the sample or that some of the depolymerization products 
are formings RTTs or other high molecular weight complexes.  
TEM of Rev-MT mixtures show that MT and RTTs are both present in these 
samples (Figure 14). MTs are shorter (≈16.4 µm compared to control MTs that were 
≈33 µm) (one-way ANOVA; p<0.0001) and their ends appeared disorganized, 
consistent with microtubule depolymerization.  Their edges appear darkly stained and 
fuzzy suggesting that Rev is coating the lattice. Measurement of fluorescently labeled 
microtubules confirms there are two-fold fewer and ≈50% shorter microtubules - 
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Figure 13: Sedimentation Assay of wild-type Rev and MTs A. Coomassie stained 
gel showing tubulin mass in the supernatant (S) and pellet (P) fraction when 
GMPCPP polymerized MT are incubated with varying concentration of wild-type 
Rev, in the presence of Mg++. B. Graphical representation of the quantification of 
tubulin heterodimers released in the (S) fraction after incubation with varying 
concentration of wild-type Rev in the presence of Mg++. C. Coomassie stained gel 
showing tubulin concentration in the (S) and (P) fraction when GMPCPP polymerized 
MT are incubated with varying concentration of wild-type Rev, in the absence of 
Mg++. D. Graphical representation of the quantification of tubulin heterodimers 
released in the (S) fraction after incubation with varying concentration of wild-type 
Rev in the absence of Mg++. Depolymerization is more efficient in the absence of 
Mg++ with p=0.01 (linear regression and Bonferroni corrections; n=49). Black stars 
represents p=0.04 (linear regression and Bonferroni corrections; n=15). Error bars 
correspond to standard deviations. 
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Figure 14: TEM analysis of Rev and its mutants with MTs. Electron micrographs 
of GMPCPP stabilized MTs treated with: A. Control buffer, B. Wild-type Rev, C. 
M4, D. M6. Black arrow in panel D points to the presence of M6 filament in the 
presence of MTs and are absent in case of wild-type Rev and M4. Magnification bar 
correspond to 200 nm. 
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-present in samples containing Rev compared to control samples (one-way ANOVA; 
p<0.001) (Figure 15).   
Measuring interactions between M4 and MTs  
Sedimentation assays demonstrate that M4 is unable to depolymerize MTs 
both in the presence and absence of Mg++ (linear regression and Bonferroni 
correction; p=0.7 and p=0.18 respectively, Figure 16). Wild-type Rev depolymerized 
microtubules better than M4 (regression and Bonferroni correction; p<0.05) (Figure 
13) and fluorescence micrographs (Figure 15) show M4 causes MTs to bundle in 
contrast to wild-type Rev that depolymerizes MTs.  
These data show that wild-type Rev and not M4 depolymerizes MTs. 
Conversely, M4 appears to stimulate MT bundling. This is consistent with the 
hypothesis that M4 mutation does not affect MT binding. Instead, the orientation of 
M4 binding is altered in a manner that allows MT cross-linking. These results are 
further consistent with the hypothesis that multimerization is important for MT 
depolymerization. 
Measuring interaction between M6 and Tubulin heterodimers  
The ability of M6 to form high molecular weight complexes with tubulin 
compared to wild-type Rev was evaluated using sedimentation assays. Because M6 
does not purified as extensively as wild-type Rev, I wished to determine the ability of 
non-specific proteins present in bacterial cell extracts to interact with tubulin. 
Addition of this control extract (total protein quantity 11 ng, corresponding to 
equivalent amount of Rev in 3 µM Rev) to tubulin heterodimers had no demonstrable 
interactions with tubulin as detected by the sedimentation assays  (Figure 17). In the 
absence of Rev, tubulin heterodimers fractionate into the supernatant indicating that 
tubulin binding proteins are not present in control bacterial extracts. In contrast to  
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Figure 15: Immunoflorescense of wild-type Rev and M4 and MTs. A. 
Immunoflorescence micrographs showing A. MT of varying size in the absence of 
Rev stained with α-tubulin antibodies. B. MT reduced in length due to 
depolymerization in the presence of wild-type Rev. C. MT bundles in the presence of 
M4. 
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Figure 16: Sedimentation Assays of M4 with MTs. A. Coomassie stained gel 
showing tubulin concentration in the supernatant (S) and pellet (P) fractions when 
GMPCPP polymerized MT are incubated with varying concentrations of M4, in the 
presence of Mg++. B. Graphical representation of the quantification of tubulin 
heterodimers released in the supernatant (S) fractions after incubation with varying 
concentrations of M4 in the presence of Mg++. C. Coomassie stained gel showing 
tubulin concentration in the supernatant (S) and pellet (P) fraction when GMPCPP 
polymerized MT are incubated with varying concentration of M4, in the absence of 
Mg++. D. Graphical representation of the quantification of tubulin heterodimers 
released in the supernatant (S) fractions after incubation with varying concentrations 
of M4 in the absence of Mg++. Error bars correspond to standard deviations. 
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Figure 17: Effect of WCE on tubulin and MTs. A. Coomassie stained gel showing 
tubulin in supernatant (S) and pellet (P) fraction after high speed centrifugation 
(360,000 x g) of tubulin alone and tubulin treated with 11 ng of whole bacterial cell 
extract (WCE). B.  Coomassie stained gel showing tubulin in supernatant (S) and 
pellet (P) fraction after high speed centrifugation (360,000 x g) of MT alone and MT 
treated with BL21(DE3) E.coli (WCE). C. Electron micrograph showing MT treated 
with WCE. D. Graphical representation of comparison showing the percentage of 
tubulin present in supernatant fraction after treatment with WCE, wild-type Rev and 
M6.
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wild-type Rev, M6 did not lead tubulin to fractionate into pelleted fractions during 
sedimentation assay (student’s t-test; p=0.42) (Figure 17, 18). TEM analysis of M6-
tubulin mixtures however detected the presence of ringed structures similar to those 
formed by wild-type Rev (Figure 10). The sizes of these rings were smaller then those 
formed by wild-type Rev (Figure 19). Similar to wild-type Rev, analysis of 1:1 M6-
tubulin heterodimer mixtures by S200 gel filtration shows that M6 forms high 
molecular weight complexes in the presence of Mg++ that elutes out in the void 
volume (Figure 8). In contrast to the results obtained with wild-type Rev, the 
stoichiometry of tubulin and M6 is altered and more heterogeneous than positive 
controls.  
In the absence of Mg++, sedimentation assays demonstrates that M6 did not 
form high molecular weight complexes in a significant manner (Student’s t-test; 
p=0.12) (Figure 18). S200 chromatography however shows that M6 retains the ability 
to bind tubulin and forms heterogeneously sized complexes, ranging in size from 150 
to 500 kDa (Figure 9). On the contrary, wild-type Rev forms complexes eluting in the 
fractions corresponding to ≈142 and 177 kDa.  
Measuring interactions between M6 and MTs  
 The ability of M6 to depolymerize MTs was analyzed by sedimentation assays 
where depolymerization was monitored by quantifying the amount of tubulin in the 
supernatant fraction. In contrast to wild-type Rev, M6 was unable to depolymerize 
MT both in the presence and absence of Mg++ (Student’s t-test; p=0.25 and p=0.34 
respectively) (Figure 20).  MT in the presence of M6 appeared healthy as compared to 
those treated by wild-type Rev, as observed by TEM (Figure 14). MT peels and rings 
were rarely seen in presence of M6 showing very little  
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Figure 18: Sedimentation Assays of M6 with tubulin. A. Representative coomassie 
stained gel showing tubulin mass in the supernatant (S) and pellet fraction (P) when 
tubulin heterodimers are incubated with varying concentration of M6, in the presence 
of Mg++. B. Graphical representation of the amount of tubulin present in supernatant 
(S) fractions after incubation with M6 (coomassie stained gel in A) in the presence of 
Mg++. C. Coomassie stained gel showing tubulin concentration in the (S) and (P) 
fraction when tubulin heterodimers are incubated with varying concentration of M6, 
in the absence of Mg++. D. Graphical representation of the amount of tubulin 
heterodimers present in supernatant (S) fractions after incubation with M6 in the 
absence of Mg++.  Error bars correspond to standard deviations.
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Figure 19: The diameters of RTTs formed by wild-type Rev and M6 are 
different. This graph plots the diameter of RTTs formed by wild-type Rev (n=81, 
black) or M6 (n=94,red) on the x-axis against the frequency of RTTs with a specific 
diameter (y-axis).  
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Figure 20: Sedimentation Assays of Rev M6 with MTs. A. Coomasie stained gel 
showing tubulin concentration in the supernatant (S) and pellet (P) fraction when 
GMPCPP polymerized MT are incubated with varying concentration of Rev M6, in 
the presence of Mg++. B. Graphical representation of the quantification of tubulin 
heterodimers released in the (S) fraction after incubation with varying concentration 
of Rev (coomasie stained gel in A) in the presence of Mg++. C. Coomasie stained gel 
showing tubulin concentration in the (S) and (P) fraction when GMPCPP polymerized 
MT are incubated with varying concentration of Rev M6, in the absence of Mg++. D. 
Graphical representation of the quantification of tubulin heterodimers released in the 
(S) fraction after incubation with varying concentration of Rev (coomasie stained gel 
in C) in the absence of Mg++. 
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sign of MT depolymerization. The occurrence of rings could be the results of M6 
interacting with small amount of background tubulin being released from MT 
spontaneously, causing ring formation. Interestingly M6 filaments were also observed 
in the presence of MTs (Figure 14), suggesting deficiency in liberation of Rev from 
M6 filaments.  
 Taken together, the results demonstrate that deletion of four arginines reduces 
the ability of Rev to depolymerize MTs. The deletions also affect ring formation by 
M6, as rings formed by M6 are smaller in size compared to those formed by wild-type 
Rev.  
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DISCUSSION 
Rev and filament formation 
The long-term goal of this study was to study the mechanism underlying Rev-
MT interactions. Table 2 summarizes the finding of this research. Specifically, one 
aim was to determine the role played by Rev-Rev interactions in RTT formation and 
MT depolymerization by comparing the ability of the M4 mutant to interact with 
tubulin relative to the wild-type protein.  The second aim was to test the hypothesis 
that the ARM, specifically residues 41-44 altered by the M6 mutation are important 
for Rev-MT interactions, specifically involved in tubulin binding. These mutations 
were used because they have well-characterized biochemical and biological effects 
(Malim et al., 1991; Battiste et al., 1996; Brice et al., 1999) and thus were a good 
place to start with Rev-MT studies. When its multimerization motifs are mutated, Rev 
lacks the ability to form high order multimers (Malim et al., 1991; Daly et al., 1993, 
1995; Auer et al., 1994; Thomas et al., 1998; Brice et al., 1999). In contrast, Rev’s 
ARM is not involved in multimerization but is critical for RRE binding and nuclear 
import (Daelmans et al., 2004).  
This work began with protein purification and its polymerization into 
filaments. Although filament formation is known to be the best way to keep Rev 
functional in the absence of high salt (Watts et al., 1998), it is not known whether 
Rev’s ability to form filaments requires the presence of the ARM and the ability to 
multimerize. The results presented here show that wild-type Rev formed filaments 
similar in width (≈13 nm) to those described by Watts et al., 1998. In the case of M4, 
no such filaments were observed, instead short oligomers were seen. The oligomers  
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Table 2: Summary of effect of Rev and its mutants on tubulin heterodimers and 
MTs. 
 
 
 
 
 
 
 
 
Sed. Assay TEM Rev 
type Tubulin  
Heterodimers 
Microtubules Tubulin  
Heterodimers 
Microtubules 
S200 Conclusion 
Wild-
type 
 
Forms high 
mol. weight 
complex, 
does not 
require Mg++ 
Releases tubulin 
heterodimers, 
both in the 
presence and 
absence of Mg++  
Forms RTTs Releases tubulin 
heterodimers, 
Forms RTTs 
Complex 
elutes in 
the void 
volume 
in the 
presence 
of Mg++ 
 
M4 Form high 
mol. weight 
complex, 
requires Mg++ 
Deficient in 
depolymerization  
Form high 
mol. weight 
complex, No 
RTTs 
Deficient in 
depolymerization, 
Causes 
microtubule 
bundling  
Complex 
elutes in 
the void 
volume 
in the 
presence 
of Mg++ 
Residues 23, 25, 
26 required for 
RTT formation 
and microtubule 
depolymerization 
M6 Does not 
form high 
mol. weight 
complex 
Deficient in 
depolymerization 
Forms 
smaller rings 
Deficient in 
depolymerization,  
Complex 
elutes in 
the void 
volume  
Residues 41-44 
important for 
RTT formation 
and microtubule 
depolymerization 
 80 
were not straight as filaments formed by wild-type Rev suggesting that there is a 
conformational change in the way one M4 interacts with the other. The absence of 
filaments showed that mutating residues 23, 25 and 26 in M4 affects Rev’s ability to 
multimerize that prevented filament formation. Although it is formally possibly that 
M4 is misfolded, other labs have successfully purified functional protein using 
comparable methods (e.g., Brice et al., 1999).  The result that M4 forms complexes 
with tubulin heterodimers with comparable apparent molecular masses to those 
formed by wild-type Rev and tubulin suggests that the mutant protein retains the 
capacity to bind tubulin.  This is consistent with the observation that M4 has 
negligible affects on RRE binding (Brice et al., 1999).  These results suggest that the 
inability of M4 to multimerize is due to mutation in Rev and does not depend upon 
the substrate with which it interacts. 
Despite the fact that M6 could not be purified to the same extent as M4 or the 
wild-type protein, M6 was successfully refolded into stereotypical filaments despite 
the presence of impurities (Figure 5). These results suggest that arginines 41-44 
deleted in M6 have a very limited role in filament formation. 
TEM analysis shows that purified Rev is in form of distinct filaments and not 
aggregated. Results of gel filtration experiments described earlier that show Rev 
eluting out with tubulin heterodimers and TEM results showing Rev forming high 
molecular weight complexes with tubulin heterodimers also suggests that Rev used 
during the experiments is not aggregated. 
Interaction between M4 and tubulin/MTs 
Watts et al. (2000) previously showed that wild-type Rev protein could bind 
and depolymerize microtubules forming RTTs in the process.  Their observation that 
Rev also forms RTTs when mixed with colchicine-treated heterodimers suggests that 
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the ability to form tubulin rings must lie with Rev since colchicine prevents tubulin 
polymerization. Therefore, if Rev is to join two different tubulin heterodimers 
together into a ring, then Rev must possess two binding sites. One will mediate the 
binding of one Rev monomer to a tubulin monomer present in the first of two adjacent 
heterodimers.  The second site must then link to the adjacent tubulin heterodimer by 
binding either to a tubulin monomer or to a second Rev monomer bound to a tubulin 
monomer.  The two models are distinguished by requirement of Rev multimerization, 
which at the very least must include dimerization.   
Use of the M4 mutant affords an opportunity to distinguish between the two 
models.  It has a well-documented effect on multimerization on the RRE while having 
only a small effect on RRE binding (Brice et al., 1999).  Moreover, the mutation is 
predicted not to interfere with Rev’s ability to bind tubulin because the affected amino 
acids (#23, #25 and #26) lie outside the putative tubulin-binding domain.  Although 
this binding site is not known with certainty, Watts et al. (2000) demonstrated that 
this activity likely resides in the N-terminal 59 amino acids and speculated that amino 
acids 34-59 are critical owing to a limited amino acid sequence similarity shared with 
Kinesin-13 proteins (Watts et al., 2000). Data from both sedimentation assays (Figure 
11), and size exclusion chromatography (Figure 8) showing that M4 readily forms 
high molecular weight complexes with tubulin (Mr≥500 kDa) are consistent with the 
hypothesis that M4 mutation does not perturb tubulin binding.  This is also confirmed 
by fluorescence immunolocalization (Figure 15). If Rev binding is sufficient to 
depolymerize microtubules, then the M4 mutation should not affect microtubule 
depolymerization. The observations that the wild-type and not the mutant protein 
depolymerizes stabilized microtubules refute this hypothesis (Figures 13 and 16). 
Thus, it seems likely that Rev-Rev interactions are as important as Rev-tubulin 
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binding events. This is not surprising.  It seems unlikely Rev has two separate binding 
sites for tubulin given its small size (116 amino acids) and that it is surprising that it 
has even one binding site given Rev’s function during HIV infection. 
Only a Rev dimer is logically required to link tubulin separate heterodimers 
into a RTT.  There are several reasons for believing that Rev is acting within an 
oligomer larger than a dimer.  First, the M4 mutation is not defective in dimerization, 
at least on its native target, the RRE (Brice et al., 1999).  Instead, the mutation 
appears to affect Rev’s ability to form high molecular weight complexes. Second, Rev 
has a propensity to form long polymers in the presence and absence of the RRE 
(Heaphy et al., 1991; Wingfield et al., 1991; Watts et al., 1998).  Moreover, the 
estimated dimensions of a Rev monomer suggest it is sufficiently big to span the 
surface of a tubulin monomer within an RTT and maintain contact with adjacent Rev 
subunits (Wingfield et al., 1991; Watts et al., 1998; Watts et al., 2000). Finally, no 
depolymerization was seen at stoichiometries as high as two Rev monomers per 
tubulin monomer (Figure 13). It seems likely that a significant number of microtubule 
ends would be bound by Rev and some depolymerization detected at this 
concentration. This conclusion may be tempered by the possibility that the M4 
mutation greatly reduces its affinity for microtubule ends and would thus require 
higher M4 concentrations.  This seems unlikely given that M4 interacts with tubulin 
heterodimers as well as the wild-type protein. 
Rev multimerization may facilitate microtubule depolymerization by several 
mechanisms. Since Rev depolymerizes microtubules from their ends (Watts et al., 
2000), multimerization along the lattice can increase the rate tubule ends are bound. 
In contrast to Kinesin-13s that diffuse across the microtubule lattice (Ogawa et al., 
2004) and kinesin-8s that actively translocate toward the microtubule plus end before 
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stimulating depolymerization (Gupta et al., 2006, Varga et al., 2006), multimerization 
is a means Rev may target microtubule ends.  How relevant this is will depend upon 
the extent multimerization is cooperative on the lattice. Indeed, Rev multimerization 
on the RRE is partially cooperative (Daly et al., 1993; Zemmel et al., 1996; Van Ryk 
and Venkatesan, 1999) and it can form polymers 40-120 nm long at moderate 
concentrations (40µg/ml) (Wingfield et al., 1991).   
Multimerization may also be important for stabilizing curved tubulin 
conformations and/or exerting sufficient force to bend protofilaments. This seems 
likely given M4’s inability to form RTTs with colchicine-treated heterodimers.  
Multimerization may be important in one of two ways (Figure 21). Multimerization 
across the microtubule surface would provide multiple contact sites in which the 
forces required to bend a protofilament might be deflected.  This is precisely the 
mechanism employed by the kinesin-13s that make multiple contacts along the 
surface of the protofilament (Moores et al., 2002; Hertzer et al., 2003; Ogawa et al., 
2004, Shipley et al., 2004). In this model, if M4 is altering the conformation of 
monomers within a Rev oligomer bound to a MT end, then the number of tubulin sites 
productively bound by Rev will decrease. The failure of M4 to depolyermize MTs is 
due to the failure to make the Rev oligomer sufficiently rigid to override the 
conformation of the intact MT.   
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Figure 21: Interaction between MTs and wild-type Rev and M4. A. Wild-type 
Rev binds and multimerizes on MT lattice and as it finds free MT ends, Rev 
oligomers stabilize the curved conformation of MT ends thus initiating RTTs 
formation. B. (i) M4 binds the MT lattice, and (ii) due to conformation change allows 
Rev monomers within an oligomer to bind tubulin out of the plane of the original 
bound MT (crosslinking), or (iii) alternatively there is no conformation change in M4 
that still just forms oligomers, binds the MT lattice like a ‘caterpillar’ and causes 
adjacent MT to crosslink with binding site opposite to each other on M4. 
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This is supported by the observation that M4 and not the wild-type protein has 
a tendency to bundle microtubules.  The ability to cross-link microtubules suggests 
that the M4 mutation is altering the orientation of Rev monomers with an oligomer 
such that MTs lying in a different plane can be bound.  This would also explain why 
M4 is deficient in multimerization on the RRE. This capacity to generate mechanical 
force is reduced in case of M4 because of the lack of ability to form higher order 
multimers.  
On the other hand it is also a possibility that the ability to multimerize may be 
arranging Rev spatially in such a way that MT binding sites are oriented in a manner 
to contact tubulin residues that control tubulin structure. Similar spatial arrangement 
is seen in case of the neck of MCAK that promotes disruption of lateral interaction 
between protofilaments and promotes MCAK diffusion on MT lattice. This ability 
being absent in M4 prevents it from depolymerization.  
Interaction between M6 and tubulin/MTs 
The ARM shares a sequence similarity with the catalytic domain of MCAK and is 
proposed to play an important role in MT binding and depolymerization (Watts et al., 
2000). If true, the M6 mutation should reduce tubulin binding, inhibit MT 
depolymerization, and block RTT formation.  Indeed, high molecular weight 
complexes are not readily detected by sedimentation assays when M6 is mixed with 
colchicine-treated tubulin.  Because these assays monitor complex formation, they do 
not differentiate between the possibilities that M6 affects tubulin binding or the 
formation of complexes after tubulin binding. Indeed RTTs are detected by TEM 
(Figure 10) albeit ring size is altered (Figure 19) suggesting that the M6 mutation 
does not elimination tubulin binding. Smaller ring diameters may be due to more 
compact and tighter arrangement of Rev within RTTs possibly increasing the tension 
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across the ring and promoting ring instability. The deletion of four positive charged 
arginines along with the introduction of one negatively charged aspartic acid and 
hydrophobic leucine might affect the conformation of the tubulin binding site. S200 
chromatography confirms M6 forms complexes with tubulin and that these complexes 
are different from complexes seen with the wild-type protein. M6 complexes in the 
presence and absence of Mg++ are smaller and heterogeneously sized (Figures 8 and 
9). Taken together, these assays collective suggest that this mutation reduces but not 
eliminates tubulin binding and alters complex formation and complex stability.   
Surprisingly, the most compelling evidence that the M6 mutation affects 
tubulin binding comes from experiments were M6 is mixed with stabilized MTs.  In 
experiments where Rev filaments are mixed with MT, substantial amounts of Rev 
filaments persist. Superficially, this could mean that M6 filaments are more stable 
than wild-type filaments and that Rev is unable to dissociate from the filament to 
interact with MT.  However, because M6 filaments are never seen in the presence of 
tubulin heterodimers, this possible explanation is untenable.  Thus, it appears that M6 
has a reduced affinity for MTs than free tubulin.  Because the exposed surface area of 
tubulin is reduced when it is in the MT polymer, it seems likely that M6 is capable of 
only binding MT ends.  
Role of Magnesium in RTT formation 
 Watts et al. (2000) has shown that Rev forms high molecular complexes with 
Rev requires Mg++. Experiments performed here are consistent with these findings. 
The role of Mg++ in RTT formation is unclear. Clearly, Mg++ by tubulin for binding 
guanine nucleotide. However, if MTs are first polymerized in the presence of Mg++ 
and then Rev is added but Mg++ concentrations are limiting, then RTTs do not form 
suggesting that Mg++ is also required for RTT formation. Although there is little 
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additional data to clarify the role of Mg++, Figure 9 (the S200 chromatography-no 
Mg++) suggests that the ability to form Rev-tubulin complexes in the absence of Mg++ 
is relieved by the M6 mutation.  Thus, if the M6 mutant is capable of only binding 
MT ends, it seems plausible to suggest that Mg++ is important for binding MT lattices.  
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FUTURE EXPERIMENTS 
 Watts et al. (2000) have suggested a limited sequence similarity between 
Rev’s ARM and the catalytic domain of MCAK (Figure 2) that extends above and 
beyond residues 41-44 mutated in M6. The role of these additional residues in Rev-
MT interactions needs investigation. Earlier experiments characterizing Rev’s 
multimerization has also shown involvement of additional residues in Rev 
multimerization-1. Analysis of the role of these residues in Rev’s ability to form 
RTTs and MT depolymerization will further shed mechanistic insights in Rev-MT 
interaction. 
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SIGNIFICANCE 
Studies conducted by Miyazaki et al. (1995) have shown that expression of 
Rev causes Cos7 cells to accumulate in G2/M phase of cell cycle. These effects were 
confirmed in HeLa cells and the cell cycle defect was localized to a point prior to the 
spindle assembly (N. Smith, personal communication). Moreover, these defects were 
also observed following expression of M4 and M6 although the severity of the defects 
was reduced (N. Smith, personal communication).  Tubulin and Rev or Rev mutants 
can be detected in immunopreciptates from whole cell extracts using tubulin- and 
Rev-specific antibodies indicating that both proteins physically interact in cells. 
Despite this, there is no compelling co-localization between Rev and MT suggesting 
that Rev must be interacting with tubulin heterodimers and not MTs (P. Kothalaxmi, 
personal communication). Since Rev accumulates perichromosomally during mitosis, 
it is spatially localized to inhibit MTs nucleating on the surface of chromatin through 
its interaction with heterodimers. This hypothesis is consistent with the results 
presented here showing that wild-type Rev, M4 and M6 each interact with 
heterodimers but only wild-type Rev is able to depolymerize stabilized MTs.  
Rev’s potential to be developed into an anti-MT agent is further reinforced as 
HIV infected cells are known to have large-scale MT pathologies. Although, MT 
pathologies observed during HIV infection has been attributed to viral protein-gp120 
(Malorni et al., 1997), the findings that Rev depolymerizes MTs and causes cell cycle 
defects suggests that gp120 may not be solely responsible and that Rev may also be 
responsible for these MT pathologies.        
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APPENDIX 
Appendix A: Primer/oligonucleotide sequence 
1) Rev mutant M4 (YSN23,25,26DDL) 
Primer sequence: 
F5’ CGT CTG ATC AAA TTC CTG GAC CAG GAT CTC CCG CCA CCG AAC CCG 3’ 
R3’ GCA GAC TAG TTT AAG GAC CTG GTC CTA GAG GGC GGT GGC TTG GGC 5’  
 
   2) Rev mutant M6 (RRRR41-44 DL) 
Primer sequence : 
F5’ CAG GCG CGC CGT AAC GAC CTT TGG CGT GAA CGT CAG 3’ 
R3’ GTC CGC GCG GCA TTG CTG GAA ACC GCA CTT GCA GTC 5’ 
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